Skip to main content
Erschienen in: Osteoporosis International 8/2015

01.08.2015 | Editorial

Overdiagnosis of osteoporosis: fact or fallacy?

verfasst von: J. Compston

Erschienen in: Osteoporosis International | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Excerpt

In their paper in the British Medical Journal, “Overdiagnosis of bone fragility in the quest to prevent hip fracture”, Järvinen et al. claim that there is inadequate evidence to support current pharmacological approaches to the prevention of hip fracture [1]. They state, correctly, that the vast majority of hip fractures follow a fall but fail to recognize the obvious connection between the consequence of a fall and bone strength. With the use of selective and misleading presentation of published evidence, they provide a biased critique of current strategies for risk assessment and prevention of hip fracture. Most surprisingly, they fail even to mention Fracture Liaison Services, a model of care that has been shown to be both effective and cost-effective in the secondary prevention of fracture and has been successfully adopted in many parts of the world [27]. …
Literatur
1.
Zurück zum Zitat Järvinen TL, Michaëlsson K, Jokihaara J, Collins GS, Perry TL, Mintzes B et al (2015) Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ 350:h2088PubMedCrossRef Järvinen TL, Michaëlsson K, Jokihaara J, Collins GS, Perry TL, Mintzes B et al (2015) Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ 350:h2088PubMedCrossRef
2.
Zurück zum Zitat Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197–1205PubMedCrossRef Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197–1205PubMedCrossRef
3.
Zurück zum Zitat Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP et al (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169:25–31PubMedCrossRef Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP et al (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169:25–31PubMedCrossRef
4.
Zurück zum Zitat Greene D, Dell RM (2010) Outcomes of an osteoporosis disease-management program managed by nurse practitioners. J Am Acad Nurse Pract 22:326–329PubMedCrossRef Greene D, Dell RM (2010) Outcomes of an osteoporosis disease-management program managed by nurse practitioners. J Am Acad Nurse Pract 22:326–329PubMedCrossRef
5.
Zurück zum Zitat McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098PubMedCrossRef McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098PubMedCrossRef
6.
Zurück zum Zitat Cooper MS, Palmer AJ, Seibel MJ (2012) Cost-effectiveness of the concord minimal trauma fracture liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23:97–107PubMedCrossRef Cooper MS, Palmer AJ, Seibel MJ (2012) Cost-effectiveness of the concord minimal trauma fracture liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23:97–107PubMedCrossRef
7.
Zurück zum Zitat Solomon DH, Patrick AR, Schousboe J, Losina E (2014) The potential economic benefits of improved post-fracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res 29:1667–1674PubMedCentralPubMedCrossRef Solomon DH, Patrick AR, Schousboe J, Losina E (2014) The potential economic benefits of improved post-fracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res 29:1667–1674PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Liu SK, Munson JC, Bell JE, Zaha RL, Mecchella JN, Tosteson AN et al (2013) Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc 61:1855–1862PubMedCentralPubMedCrossRef Liu SK, Munson JC, Bell JE, Zaha RL, Mecchella JN, Tosteson AN et al (2013) Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc 61:1855–1862PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928PubMedCrossRef Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928PubMedCrossRef
10.
11.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995PubMedCrossRef Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995PubMedCrossRef
12.
Zurück zum Zitat Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Osteoporotic Fractures Research Group et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18:1947–1954PubMedCrossRef Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Osteoporotic Fractures Research Group et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18:1947–1954PubMedCrossRef
16.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57PubMedCentralPubMedCrossRef Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Silva RB, Eslick GD, Duque G (2013) Exercise for falls and fracture prevention in long term care facilities: a systematic review and meta-analysis. J Am Med Dir Assoc 14:685–689PubMedCrossRef Silva RB, Eslick GD, Duque G (2013) Exercise for falls and fracture prevention in long term care facilities: a systematic review and meta-analysis. J Am Med Dir Assoc 14:685–689PubMedCrossRef
19.
Zurück zum Zitat Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 9:CD007146PubMed Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 9:CD007146PubMed
20.
Zurück zum Zitat El-Khoury F, Cassou B, Charles MA, Dargent-Molina P (2013) The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials. BMJ 347:f6234PubMedCentralPubMedCrossRef El-Khoury F, Cassou B, Charles MA, Dargent-Molina P (2013) The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials. BMJ 347:f6234PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Black D, Cummings S, Karpf D, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedCrossRef Black D, Cummings S, Karpf D, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedCrossRef
22.
Zurück zum Zitat McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef
23.
Zurück zum Zitat Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822PubMedCrossRef Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822PubMedCrossRef
24.
Zurück zum Zitat Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, FREEDOM Trial et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765PubMedCrossRef Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, FREEDOM Trial et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765PubMedCrossRef
25.
Zurück zum Zitat Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, HORIZON Pivotal Fracture Trial et al (2009) Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab 94:3215–3225PubMedCrossRef Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, HORIZON Pivotal Fracture Trial et al (2009) Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab 94:3215–3225PubMedCrossRef
26.
Zurück zum Zitat Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, for the HORIZON Recurrent Fracture Trial et al (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:nihpa40967PubMedCentralPubMedCrossRef Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, for the HORIZON Recurrent Fracture Trial et al (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:nihpa40967PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Greenspan SL, Perera S, Ferchak MA, Nace DA, Resnick NM (2015) Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med 175:913–921PubMedCrossRef Greenspan SL, Perera S, Ferchak MA, Nace DA, Resnick NM (2015) Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med 175:913–921PubMedCrossRef
28.
Zurück zum Zitat Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, GLOW investigators et al (2012) Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int 23:2863–2871PubMedCrossRef Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, GLOW investigators et al (2012) Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int 23:2863–2871PubMedCrossRef
29.
Zurück zum Zitat Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52:1832–1839PubMedCrossRef Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52:1832–1839PubMedCrossRef
30.
Zurück zum Zitat Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, FIT Research Group et al (2005) Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20:971–976PubMedCrossRef Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, FIT Research Group et al (2005) Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20:971–976PubMedCrossRef
31.
Zurück zum Zitat Boonen S, Black DM, Colón-Emeric CS, Eastell R, Magaziner JS, Eriksen EF et al (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58:292–299PubMedCentralPubMedCrossRef Boonen S, Black DM, Colón-Emeric CS, Eastell R, Magaziner JS, Eriksen EF et al (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58:292–299PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Kanis JA, Hiligsmann M (2014) The application of health technology assessment in osteoporosis. Best Pract Res Clin Endocrinol Metab 28:895–910PubMedCrossRef Kanis JA, Hiligsmann M (2014) The application of health technology assessment in osteoporosis. Best Pract Res Clin Endocrinol Metab 28:895–910PubMedCrossRef
33.
Zurück zum Zitat Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY et al (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 33:205–224PubMedCrossRef Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY et al (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 33:205–224PubMedCrossRef
Metadaten
Titel
Overdiagnosis of osteoporosis: fact or fallacy?
verfasst von
J. Compston
Publikationsdatum
01.08.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3220-0

Weitere Artikel der Ausgabe 8/2015

Osteoporosis International 8/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.